
Bryocetum 50mg Tablet
Marketer
Ideal Life Sciences Pvt Ltd
Salt Composition
Brivaracetam (50mg)
Overview Bryocetum 50mg Tablet
Epilepsia-50 is an anticonvulsant medication prescribed to manage epileptic seizures. It's effective as a monotherapy or in combination with other treatments, providing ongoing seizure control with consistent use. Epilepsia-50 works by reducing aberrant brain electrical activity. Administer it regularly, with or without food, but maintain a consistent daily schedule for optimal results. Dosage and frequency are determined by your physician to effectively control seizures, potentially increasing gradually. It's typically a long-term therapy; continue taking it as directed, even if feeling well, as discontinuation or missed doses may exacerbate seizures. Never cease treatment without your doctor's instruction, as abrupt withdrawal can worsen seizures. Common side effects include dizziness, headache, nausea, and vomiting. Behavioral shifts, aggression, irritability, and agitation may also occur, often more prevalent initially, subsiding as tolerance develops. While most side effects are minor, some may be serious; seek medical attention if necessary. Suicidal ideation has been reported in a small percentage of patients; notify your doctor immediately if your mood deteriorates. Prior to commencing treatment, inform your physician of any liver or kidney issues, depression, suicidal thoughts, pregnancy, or pregnancy plans. Nursing mothers should also seek medical counsel before use.
Primary Ingredients of Bryocetum 50mg Tablet
No text was provided to rewrite.
Uses of Bryocetum 50mg Tablet
Convulsive disorders
Major Benefits of Bryocetum 50mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the 50mg Bryocetum tablet whole; avoid crushing, chewing, or fracturing it. Consumption with or without food is acceptable, although consistent daily timing is recommended.
Common Side effects of Bryocetum 50mg Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Bryocetum 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 50mg Bryocetum tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Bryocetum 50mg Tablet works:
Epilepsy treatment Bryocetum 50mg tablets target nerve cell receptors (SV2A) to modulate their function. This action reduces excessive neuronal activity within the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption while taking Bryocetum 50mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Bryocetum 50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Bryocetum 50mg tablets with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 50mg Bryocetum tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Bryocetum 50mg tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. However, its use is not recommended for patients with end-stage renal disease given the absence of supporting clinical trial evidence.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Bryocetum 50mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Bryocetum 50mg Tablet :
NA
Facts to Know About Bryocetum 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Action Class | AED: A protein ligand within synaptic vesicle 2 |
